rosiglitazone has been researched along with Rheumatoid Arthritis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Li, H; Li, J; Li, XF; Song, B; Wang, H; Wu, S; Wu, YY; Yang, YL; Yin, SQ | 1 |
| Cho, M; Choi, S; Kim, J; Kim, SR; Kwon, EJ; Park, EJ | 1 |
| Bianchi, A; Jouzeau, JY; Koufany, M; Moulin, D; Netter, P; Sebillaud, S | 1 |
| Cho, YS; Heo, JY; Kim, CH; Song, JS | 1 |
1 review(s) available for rosiglitazone and Rheumatoid Arthritis
| Article | Year |
|---|---|
[Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases - the pro and con of agonists].
Topics: Animals; Arthritis, Rheumatoid; Chromans; Dimerization; Extracellular Matrix; Humans; Hypoglycemic Agents; Joint Diseases; Osteoarthritis; Peroxisome Proliferator-Activated Receptors; PPAR alpha; PPAR-beta; Rosiglitazone; Thiazolidinediones; Troglitazone | 2008 |
3 other study(ies) available for rosiglitazone and Rheumatoid Arthritis
| Article | Year |
|---|---|
PPAR-γ alleviates the inflammatory response in TNF-α-induced fibroblast-like synoviocytes by binding to p53 in rheumatoid arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Proliferation; Cells, Cultured; Fibroblasts; Humans; Inflammation; Mice; Pioglitazone; PPAR gamma; Rats; Rosiglitazone; Synovial Membrane; Synoviocytes; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2023 |
PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cell Movement; Cells, Cultured; Cysteine-Rich Protein 61; Dose-Response Relationship, Drug; Down-Regulation; Fibroblasts; Humans; NF-kappa B; NF-KappaB Inhibitor alpha; Phenotype; PPAR gamma; Rosiglitazone; Signal Transduction; Synovial Membrane; Synoviocytes; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2017 |
Rosiglitazone reduces a wide range of proinflammatory profiles in synovial fibroblast SW982 under spheroid culture.
Topics: Animals; Ankle Joint; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Line; Fibroblasts; Humans; Male; Mice; Mice, Inbred DBA; Rosiglitazone; Spheroids, Cellular; Synovial Membrane; Thiazolidinediones; Treatment Outcome | 2010 |